News Under pressure, Novo lays out blockbuster launch plans Novo has revealed a plan to launch five or more blockbusters between now and 2030 that it hopes will grow annual revenues by around $23bn.
News Novo Nordisk rebrands as Novo as new CEO charts turnaround Embroiled in a fight to retain market share in weight loss and diabetes therapies, Novo Nordisk has rebranded and launched a new corporate culture.
News Bayer gets €3bn from Apollo for contraceptives unit stake Bayer has partnered with private equity group Apollo to set up a new entity that will handle its long-acting contraceptives products.
News Sanofi names ex-Roche exec Fontoura as R&D chief Paulo Fontoura, currently chief medical officer of Xaira Therapeutics, will replace Houmab Ashrafian as Sanofi's R&D head on 1st September.
Digital Sponsored Remove the friction to unlock the true potential of AI: Prec... Frictionless AI is the foundation for Precision Intelligence: insight that is not simply faster or broader, but more decision-relevant.
R&D Sponsored 12 Questions with Faruk Uzman Find out more about Faruk Uzman, VP EMEA at Boston Scientific, in a new 12 Questions With.
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.